US2013331568A1PendingUtilityA1

Acetylene derivatives having mglur 5 antagonistic activity

54
Assignee: GASPARINI FABRIZIOPriority: Dec 4, 2001Filed: Aug 15, 2013Published: Dec 12, 2013
Est. expiryDec 4, 2021(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/34A61P 25/28A61P 25/32A61P 25/30A61P 25/14A61P 25/24A61P 25/00A61P 25/22A61P 25/18A61P 25/16A61P 29/00A61P 25/08A61P 25/36A61P 25/04C07C 271/16C07D 209/44C07D 209/08C07D 405/06C07D 405/12C07D 401/06C07D 401/04C07D 215/08C07D 215/20A61P 9/10C07C 271/24C07C 233/23
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compounds of formula I wherein n, A, R, R′, R″, R 0 , X and Y are as defined in the description, and their preparation. The compounds of formula I are useful as pharmaceuticals.

Claims

exact text as granted — not AI-modified
1 . A compound of formula I 
       
         
           
           
               
               
           
         
       
       wherein
 m is 0 or 1, 
 n is 0 or 1 and 
 A is hydroxy 
 X is hydrogen and 
 Y is hydrogen, or 
 A forms a single bond with X or with Y; 
 R 0  is hydrogen. (C 1-4 )alkyl, (C 1-4 )alkoxy, trifluoromethyl, halogen, cyano, nitro, —COOR 1  wherein R 1  is (C 1-4 )alkyl or —COR 2  wherein R 2  is hydrogen or (C 1-4 )alkyl, and 
 R is —COR 3 , —COOR 3 , —CONR 4 R 5  or —SO 2 R 6 , wherein R 3  is (C 1-4 )alkyl, (C 3-7 )cycloalkyl or optionally substituted phenyl, 2-pyridyl or 2-thienyl, R 4  and R 5 , independently, are hydrogen or (C 1-4 )alkyl and R 3  is (C 1-4 alkyl, (C 3-7 )cycloalkyl or optionally substituted phenyl, 
 R′ is hydrogen or (C 1-4 )alkyl and 
 R″ is hydrogen or (C 1-4 )alkyl, or 
 R′ and R″ together form a group —CH 2 —(CH 2 ) p —
 wherein p is 0, 1 or 2, in which case one of n and p is different from 0, 
 
 
       with the proviso that R 0  is different from hydrogen, trifluoromethyl and methoxy when m is 1, n is 0, A is hydroxy, X and Y are both hydrogen, R is COOEt and R′ and R″ together form a group —(CH 2 ) 2 —, 
       in free base or acid addition salt form.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.